Research Projects
Depression and anxiety are common, debilitating and chronic mental health conditions which can be difficult to effectively treat. We aim here to...
Supervisor: Assoc Professor Nigel Jones
Project Aims: Identify genetic markers that predict the risk of valproate-induced birth defects.
It is recognised that women with epilepsy who...
Supervisor: Professor Terence O'Brien
Alzheimer's disease (AD) patients are 10 times more likely to develop epilepsy compared with age-matched controls. The treatment of recurrent...
Supervisor: Professor Patrick Kwan
Gliomas are the most common type of intrinsic brain tumour and a major cause of morbidity and mortality for those afflicted by these highly invasive...
Supervisor: Dr Mastura Monif
Magnetic Resonance Imaging (MRI) represents the gold standard for radiological diagnosis and monitoring of neurological diseases such as multiple...
Supervisor: Dr Scott Kolbe
Are Multiple Sclerosis therapies more effective in younger people with MS than older people with MS?
Multiple sclerosis, an autoimmune, neurodegenerative condition, is the most common cause of non-traumatic neurological disability in young adults....
Supervisor: Dr Vilija Jokubaitis
Post-traumatic epilepsy (PTE) is a recurrent seizure disorder due to brain injury following physical trauma. PTE accounts for 20% of symptomatic...
Supervisor: Miss Rui Li
The glymphatic pathway has been proposed as a key contributor to the clearance of fluid and metabolic waste products, such as amyloid beta and tau,...
Supervisor: Associate Professor David Wright
A biomarker is an objectively measured characteristic of a normal or pathologic biological process. The development of novel interventions to treat,...
Supervisor: Dr Pablo Casillas-Espinosa MD, PhD
Schizophrenia is a complex neuropsychiatric condition with a broad symptom profile, and current treatments are inadequate in many patients. In...
Supervisor: Assoc Professor Nigel Jones
Introduction:
ACTIVE-MS is a highly innovative patient participation study that will be conducted in 300 people with relapsing MS at risk of...
Supervisor: Assoc Professor Anneke Van Der Walt
Multiple sclerosis, an autoimmune, neurodegenerative condition, is the most common cause of non-traumatic neurological disability in young adults....
Supervisor: Dr Vilija Jokubaitis
Genetic variants have been found to cause epilepsy as well as affect how people respond to treatment. Whole exome sequencing is a new method of...
Supervisor: Professor Patrick Kwan
Schizophrenia is a complex psychiatric condition, and existing medications are not satisfactory. In particular, cognitive symptoms of schizophrenia,...
Supervisor: Dr Matt Hudson
The application of whole genome sequencing (WGS) in the clinical care of patients with epilepsy is increasingly viable as the cost of these assays...
Supervisor: Professor Patrick Kwan
A common set of pathological processes contribute to most, if not all, neurodegenerative diseases. The processes include chronic activation of...
Supervisor: Dr Ian Harding
Friedreich ataxia (FRDA) and Spinocerebellar ataxia’s (SCA’s) are rare, genetic neurodegenerative diseases that are associated with profound and...
Supervisor: Dr Ian Harding
Approximately 150,000 people are currently living with focal epilepsy in Australia, and over one third have seizures which cannot be controlled with...
Supervisor: Dr Andrew Neal
Point-of-care (POC) testing is the testing at the site of patient care. It is done on patients conveniently and immediately allowing patients and...
Supervisor: Professor Patrick Kwan
Multiple sclerosis (MS), an autoimmune, neurodegenerative condition, that affects almost 26,000 Australians. It is characterised by inflammatory...
Supervisor: Dr Vilija Jokubaitis